A New Phase in the Rollback of Abortion Access
President & CEO Dr. Jamila Perritt discusses how the Texas judge’s injunction on the use of mifepristone has further eroded the country’s standing as a […]
President & CEO Dr. Jamila Perritt discusses how the Texas judge’s injunction on the use of mifepristone has further eroded the country’s standing as a […]
President & CEO Dr. Jamila Perritt discusses the impact on women’s healthcare of the Texas judge’s ruling and what’s next in the legal fight.
Fellows Ashley Jeanlus & Gopika Krishna share how the ruling on mifepristone by a Texas district judge may impact women.
Our Fellow Smita Carroll comments on the ruling by a Texas district judge attempting to stay the FDA’s approval of mifepristone, America’s most commonly-used abortion […]
President & CEO Dr. Jamila Perritt speaks out against a Texas court decision that blocks preventative care coverage.
Our Fellow Dr. Mollie Nisen based in Washington state shares how the uptick in out-of-state demand for reproductive healthcare impacts both doctors and patients.
Our Fellow Smita Carroll spoke to Newsweek about how carrying a pregnancy to term has more risks than abortion care.
Our Fellow Michael Belmonte writes about how the dangerous ideology of abortion “reversal” should not be part of medical practice or public policy.